What drugs does ENDO OPERATIONS make?

ENDO OPERATIONS has 22 FDA-approved drugs including AVEED.

What therapeutic areas does ENDO OPERATIONS focus on?

ENDO OPERATIONS focuses primarily on Oncology and Respiratory and 1 other therapeutic areas.

Data updated: Mar 10, 2026

ENDO OPERATIONS

OncologyRespiratoryNeurology

Specialty

ENDO OPERATIONS is a specialty pharmaceutical company focused on Oncology, Respiratory, Neurology. Key products include AVEED.

1950

Since

Drugs

Trials

Approved (2yr)

Key Drugs

AVEED

testosterone undecanoate

1 indications · 2014

Recent Activity

SUPPRELIN LA 2025-09-23

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 33%

1 drugs

Respiratory 33%

1 drugs

Neurology 33%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

GSK big-pharma

Respiratory, Oncology, Neurology

Roche big-pharma

Oncology, Neurology, Respiratory

GE HEALTHCARE specialty

Neurology, Oncology, Respiratory

Novartis big-pharma

Oncology, Respiratory

AbbVie big-pharma

Oncology, Neurology

ENDO OPERATIONS

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (22)

Active (10)

Discontinued (12)

Company Info